GeneChem Technologies Venture Fund L.P. was launched in early 1997  to take advantage of the increasing opportunities afforded by the emerging genomics sector. With committed capital of $100 million, we invested this first focused fund by targeting companies active in the field of genomics, which we defined as gene discovery, functional genomics, bio-informatics, proteomics and gene therapy. The companies in our portfolio developed tools, platforms or were involved in drug discovery.

This fund is no longer seeking new investments.